[1]
Yıldırım, S. et al. 2025. Impact of Blood Type on Treatment Response and Survival in HER2-Negative Metastatic Gastric Cancer. Cerrahpaşa Medical Journal. 49, 1 (Oct. 2025), 1–6. DOI:https://doi.org/10.5152/cjm.2025.25042.